Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.
Open accessAbstract
The insulin receptor substrate proteins IRS1 and IRS2 are key targets of the insulin receptor tyrosine kinase and are required for hormonal control of metabolism. Tissues from insulin-resistant and diabetic humans exhibit defects in IRS-dependent signalling, implicating their dysregulation in the initiation and progression of metabolic disease. However, IRS1 and IRS2 are regulated through a complex mechanism involving phosphorylation of >50 serine/threonine residues (S/T) within their long, unstructured tail regions. In cultured cells, insulin-stimulated kinases (including atypical PKC, AKT, SIK2, mTOR, S6K1, ERK1/2 and ROCK1) mediate feedback (autologous) S/T phosphorylation of IRS, with both positive and negative effects on insulin sensitivity. Additionally, insulin-independent (heterologous) kinases can phosphorylate IRS1/2 under basal conditions (AMPK, GSK3) or in response to sympathetic activation and lipid/inflammatory mediators, which are present at elevated levels in metabolic disease (GRK2, novel and conventional PKCs, JNK, IKKβ, mPLK). An emerging view is that the positive/negative regulation of IRS by autologous pathways is subverted/co-opted in disease by increased basal and other temporally inappropriate S/T phosphorylation. Compensatory hyperinsulinaemia may contribute strongly to this dysregulation. Here, we examine the links between altered patterns of IRS S/T phosphorylation and the emergence of insulin resistance and diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Insulin resistance in adipocytes is associated with impaired phosphorylation of IRS-1 in obesity, which is further impaired in T2DM.
“Insulin resistance in adipocytes is associated with impaired phosphorylation of insulin receptor substrate 1 (IRS-1) in obesity, which is further impaired in T2DM”
From Effect of Exercise Training on Fat Loss—Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution (2021) · cites this paper as Copps and White, 2012
The section on insulin-regulated S/T kinases reports that insulin-stimulated IRS1 S307 phosphorylation correlates with insulin sensitivity in human adipocytes and is decreased in adipocytes from people with type 2 diabetes (page not available). It does not establish that phosphorylation is already impaired in adipocytes in obesity or that it declines further with diabetes. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
3 retracted
Insulin Stimulates PKCζ-mediated Phosphorylation of Insulin Receptor Substrate-1 (IRS-1)
Liu, Y., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. R., Ohba, M., Kuroki, T., LeRoith, D., & Zick, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007281200 · Cited by 158 · see citing works
RetractedHerschkovitz, A., Liu, Y., Ilan, E., Ronen, D., Boura‐Halfon, S., & Zick, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610949200 · Cited by 97 · see citing works
RetractedG Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity
García‐Guerra, L., Nieto-Vázquez, I., Vila‐Bedmar, R., Jurado-Pueyo, M., Zalba, G., Dı́ez, J., Murga, C., Fernández‐Veledo, S., Mayor, F., & Lorenzo, M. (2010) · Diabetes · doi:10.2337/db10-0771 · Cited by 92 · see citing works
RetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 2× · see citing works
“In contrast, ‘priming’ phosphorylation of AKT at S473—by mammalian target of rapamycin (mTOR) complex 2 (mTORC2) [21] (Fig.”
BackgroundEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1× · see citing works
“phosphorylation is frequently used as evidence of insulin resistance (or its resolution) in mice, despite the influence of insulin on S307 phosphorylation and the probable contribution of other phospho-S/Ts [44].”
BackgroundNewgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165 · cited 1× · see citing works
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 2× · see citing works
“Prospective studies first identify insulin resistance in human skeletal muscle, which is thought to contribute, via a dys-metabolic process, to the emergence of phenotypic disease [3, 74].”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,837 · cited 2× · see citing works
“but not Akt1, gene deletion in mice causes a diabetes-like phenotype [22].”
BackgroundAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 3× · see citing works
“1b); S6K2 can also phosphorylate IRS1 in vitro, but does not compensate for loss of S6K1 in knockout mice [51, 106].”
BackgroundDirect Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D., Cantley, L., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,609 · cited 1× · see citing works
“Recruitment of dimeric PI3K (p85•p110) to IRS produces membrane phosphatidylinositol 3,4,5-trisphosphate (PIP3), which recruits the S/T kinase AKT [19].”
BackgroundAdipose tissue as an endocrine organ
Galić, S., Oakhill, J. S., & Steinberg, G. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,597 · cited 1× · see citing works
“IKKβ and JNK—Impaired glucose uptake and/or insulin resistance within adipose tissue can contribute to the development of type 2 diabetes [164], likely by altering its secretion of adipokines, such as adiponectin or retinol-binding protein 4 (reviewed in [165]).”
BackgroundYu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 2× · see citing works
“NEFA levels causes insulin resistance in rats, accompanied by elevated muscle IRS1 S307 (hS312) phosphorylation [146].”
BackgroundSelf-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487 · cited 2× · see citing works
“Treatment of CHO cells with the low-specificity JNK agonist anisomycin was used to identify S307 (hS312) near the IRS1 PTB domain as a major site of phosphorylation [38].”
BackgroundMethodSelf-citationItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · cited 2× · see citing works
“Lipid infusion in humans can also activate muscle PKCδ and (canonical) PKCβ2 [154].”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · see citing works
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294 · cited 2× · see citing works
“The activation/levels of two other IRS kinases, ROCK1 and G protein-coupled receptor kinase 2 (GRK2), is mechanistically independent of IRS [20] but is clearly influenced by insulin and altered in type 2 diabetes [88–90].”
BackgroundGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · cited 2× · see citing works
“Intramyocellular diacylglycerol can be generated in humans and rodents by normal phospholipid metabolism or, experimentally, by the infusion of TAG emulsions plus heparin to activate tissue lipase [153].”
BackgroundMethodSelf-citationInsulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 1× · see citing works
“Additionally, the expanded adipose compartment in diabetes/obesity produces proinflammatory cytokines such as TNFα and IL1β that can contribute to insulin resistance systemically (reviewed in [79]).”
BackgroundLipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189 · cited 4× · see citing works
“intramyocellular TAG , hepatosteatosis) (reviewed in [74]).”
BackgroundInfluentialCusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · cited 4× · see citing works
“In contrast with AKT, basal or insulin-stimulated ERK1/2 activation in diabetic muscle is unchanged or increased in several studies, compatible with its partial independence from IR/IRS [82, 86].”
BackgroundResultInfluentialThe TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Толкачева, Т. А., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123 · cited 1× · see citing works
“It can now be appreciated that feedback S/T phosphorylation of IRS by mTORC1 and/or S6K1 underlies their disappearance during persistent insulin stimulation [49, 50].”
BackgroundHsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084 · cited 2× · see citing works
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphor-ylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulat…”
BackgroundAguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 2× · see citing works
“In cultured cells that produce very little IRS2, insulin stimulates S307 phosphorylation via a PI3K pathway requiring the IRS1 YXXM motifs [39, 40].”
BackgroundSelf-citationSelective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 959 · see citing works
Morino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 3× · see citing works
“Given their co-incidence and propensity to aggravate one another, it cannot be stated whether hyperinsulinaemia or dyslipidaemia (or still other factors) underlie increased IRS S/T phosphorylation in the pre-diabetic period [85].”
BackgroundInfluentialBlüher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B., & Kahn, C. R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00199-5 · Cited by 806 · cited 1× · see citing works
“in all tissues, exhibit abnormal or severely compromised adipocyte differentiation [16, 17].”
BackgroundShah, O. J., Wang, Z., & Hunter, T. R. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 800 · cited 1× · see citing works
“It can now be appreciated that feedback S/T phosphorylation of IRS by mTORC1 and/or S6K1 underlies their disappearance during persistent insulin stimulation [49, 50].”
BackgroundSerine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex
Gao, Z., Hwang, D. H., Bataille, F., Lefevre, M., York, D. A., Quon, M. J., & Ye, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209459200 · Cited by 777 · cited 1× · see citing works
“In contrast, in mammalian cells, IKKβ physically associates with IRS1, and its TNFα-stimulated activity correlates with phosphorylation of mS307/hS312—consistent with IKKβ phosphorylation of this residue in vitro [167].”
BackgroundThe role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759 · see citing works
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 1× · see citing works
“IKKβ and JNK—Impaired glucose uptake and/or insulin resistance within adipose tissue can contribute to the development of type 2 diabetes [164], likely by altering its secretion of adipokines, such as adiponectin or retinol-binding protein 4 (reviewed in [165]).”
BackgroundLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 1× · see citing works
“Thus, though AKT signalling to mTORC1 is diminished in diabetes, the over-supply of nutrients in obesity is hypothesised to promote mTORC1/S6K phosphorylation of IRS and other targets, aggravating insulin resistance (reviewed in [109, 110]).”
BackgroundInsulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733 · cited 17× · see citing works
“IRS2 (but not IRS1) protein concentration in mouse liver is decreased during refeeding via a PI3K-dependent mechanism [68].”
BackgroundInfluentialFROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Biddinger, S. B., & Kahn, C. R. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124723 · Cited by 700 · cited 1× · see citing works
“It also underlies risk factors—including hyperglycaemia, dyslipidaemia and hypertension—for the clustering of type 2 diabetes with cardiovascular disease, non-alcoholic fatty liver disease and related maladies (metabolic syndrome) [2].”
BackgroundNutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1
Um, S. H., D'Alessio, D., & Thomas, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.003 · Cited by 690 · cited 2× · see citing works
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundPlomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627 · cited 4× · see citing works
“TNFα activates multiple kinases in muscle, including S6K, ERK1/2, IKKβ and the IRS1 mS307/hS312 kinase JNK1; however, muscle hS312 phosphorylation is not significantly elevated by TNFα infusion prior to the period in which TNFα causes reduced IRS1 tyrosine phosphorylation and insulin resistance [34].”
BackgroundInfluentialRui, L., Aguirre, V., Kim, J. K., Shulman, G. I., Lee, A., Corbould, A. M., Dunaif, A. E., & White, M. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10934 · Cited by 600 · cited 3× · see citing works
“Other agents—including insulin in rodent and human tissues—can stimulate phosphorylation of S307 via JNK-independent pathways [39].”
BackgroundSelf-citationPhosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598 · cited 6× · see citing works
“Thus, S/T phosphorylation at many sites together converts IRS proteins to an inactive state, separable from their inactivation by degradation; it was further suggested that this ‘array phosphorylation’ of IRS (particularly within the PTB-proximal regions) is necessary for the desensitisation of insulin signalling by d…”
BackgroundInfluentialRole that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594 · cited 1× · see citing works
“Comparison of knock-in mice with constitutively active GSK3 isoforms (α, β, or α and β) demonstrates the predominance of GSK3β in muscle, yet none of these mice show impaired AKT activation or become diabetic [140].”
BackgroundKhamzina, L., Veilleux, A., Bergeron, S., & Marette, A. (2005) · Endocrinology · doi:10.1210/en.2004-0921 · Cited by 562 · cited 1× · see citing works
“Rodents fed a high-fat diet to cause obesity and insulin resistance show increased basal mTORC1→S6K activation in metabolic tissues, with pronounced phosphorylation of IRS1 at S632 and/or S302 (hS636, hS307) [106, 115].”
BackgroundEpinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 560 · cited 1× · see citing works
“The correlation between excessive β-adrenergic activity and insulin resistance has long been noted [131].”
BackgroundA Molecular Basis for Insulin Resistance
Paz, K., Hemi, R., LeRoith, D., Karasik, A., Elhanany, E., Kanety, H., & Zick, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29911 · Cited by 553 · see citing works
Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 550 · see citing works
Reaven, G. M. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.002 · Cited by 506 · cited 1× · see citing works
“Insulin resistance, defined as reduced responsiveness of tissues to normal insulin concentrations, is a principal feature of type 2 diabetes, which leads to compensatory hyperinsulinaemia [1].”
BackgroundPKC-θ knockout mice are protected from fat-induced insulin resistance
Kim, J. K., Fillmore, J. J., Sunshine, M. J., Albrecht, B., Higashimori, T., Kim, D.-W., Liu, Z.-X., Soos, T. J., Cline, G. W., O’Brien, W. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422230 · Cited by 500 · cited 2× · see citing works
“5 mmol/l NEFA) impairs muscle IRS1 tyrosine phosphorylation, PI3K activity and glucose disposal, and these effects are lost in Prkcq (PKCθ) knockout mice [147].”
BackgroundSamuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1× · see citing works
“Rodent and human studies validate the contribution of dyslipidaemia to skeletal muscle and liver insulin resistance via diacylglycerol-mediated activation of nPKCs, including PKCθ [65, 146, 147], PKCδ [148] and PKCε [149, 150] (reviewed in [74, 94]).”
BackgroundBidirectional modulation of insulin action by amino acids.
Patti, M., Brambilla, E., Luzi, L., Landaker, E. J., & Kahn, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1326 · Cited by 491 · cited 1× · see citing works
“Nonetheless, mTORC1/S6K can be stimulated by nutrients independently of IRS [107]—most clearly by branched-chain amino acids (BCAA) such as leucine [108].”
BackgroundElevated plasma endothelin in patients with diabetes mellitus
Takahashi, K., Ghatei, M. A., Lam, H. ‐., O’Halloran, D., & Bloom, S. R. (1990) · Diabetologia · doi:10.1007/bf00403325 · Cited by 489 · cited 1× · see citing works
“Increased plasma concentration of the vasoconstrictive ET-1 polypeptide is associated with insulin resistance and/or hypertension [128, 129], which is, in turn, promoted by direct and indirect (sympathoadrenal and angiotensin II-dependent) effects of compensatory hyperinsulinaemia to cause sodium retention (reviewed i…”
BackgroundBiddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469 · see citing works
Pleiotropic Insulin Signals are Engaged by Multisite Phosphorylation of IRS-1
Sun, X., Crimmins, D. L., Myers, M. G., Miralpeix, M., & White, M. F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7418 · Cited by 466 · see citing works
Self-citationTremblay, F., Brûlé, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706517104 · Cited by 465 · cited 26× · see citing works
“Mice lacking mTOR or raptor in muscle, or S6K1 in all tissues, highlight the role of mTORC1→S6K signalling in the growth and maintenance of skeletal muscle (reviewed in [107]).”
BackgroundInfluentialDong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 2× · see citing works
“Insulin stimulation of the RAS→mitogen-activated protein kinase (MAPK) cascade depends partly on other substrates of the IR, such as SHC, yet activation of the MAPKs extracellular signal-regulated kinase-1 and -2 (ERK1/2) is impaired in IRSdeficient mouse liver [11].”
BackgroundSelf-citationInsulin signaling meets mitochondria in metabolism
Cheng, Z., Tseng, Y. D., & White, M. F. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.005 · Cited by 449 · cited 1× · see citing works
“The binding of insulin to the insulin receptor (IR), and in muscle tissues to hybrid insulin/ IGF1 receptors (IR/IGF1R) [7], promotes the autophosphorylation of a trio of regulatory loop tyrosine residues, disinhibiting IR tyrosine kinase activity toward IRS [8].”
BackgroundSelf-citationc-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 441 · cited 1× · see citing works
“mTOR complex 1 (mTORC1) can mediate insulin- or anisomycin-stimulated S307 phosphor-ylation [41], casting some doubt on the significance of insulin-stimulated JNK phosphorylation of S307 observed in cultured cells [42].”
BackgroundSelf-citationTanti, J.-F., & Jager, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.004 · Cited by 430 · cited 4× · see citing works
“However, as reviewed herein and elsewhere [5, 6], unique phospho-S/T on IRS1 can have negative (or positive) effects on insulin signalling that are currently unexplainable in either structural terms or by a requirement for multiple phosphorylation.”
BackgroundInfluentialCharacterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
Dibble, C. C., Asara, J. M., & Manning, B. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00735-09 · Cited by 420 · cited 1× · see citing works
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphorylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulati…”
BackgroundInsulin modulates gluconeogenesis by inhibition of the coactivator TORC2
Dentin, R., Liu, Y., Koo, S., Hedrick, S. A., Vargas, T., Heredia, J., Yates, J. R., & Montminy, M. (2007) · Nature · doi:10.1038/nature06128 · Cited by 400 · cited 3× · see citing works
“However, SIK2 kinase activity is positively regulated by insulin via phosphorylation by AKT2 [144], suggesting an autologous feedback role in the regulation of IRS.”
BackgroundTzatsos, A., & Kandror, K. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.63-76.2006 · Cited by 399 · cited 3× · see citing works
“Surprisingly—given the apparent involvement of phospho-S632 (hS636) in desensitisation of insulin signalling [53, 91]—double mutation of S632/ 635 to alanine in CHO cells reduces IRS1 tyrosine phosphorylation and PI3K binding [71].”
BackgroundTremblay, F., Krebs, M., Dombrowski, L., Brehm, A., Bernroider, E., Roth, E., Nowotny, P., Waldhäusl, W., Marette, A., & Roden, M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2674 · Cited by 370 · cited 1× · see citing works
“In contrast, infusion of complex amino acid mixtures (AA) into humans with clamped hyperinsulinaemia (to repress gluconeogenesis from amino acid precursors) decreases the rate of glucose disposal by about a third, with post-clamp muscle biopsies showing decreased IRS1 tyrosine phosphorylation and increased phosphoryla…”
BackgroundFunctional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D. (2001) · Genes & Development · doi:10.1101/gad.908001 · Cited by 369 · cited 1× · see citing works
“The binding of insulin to the insulin receptor (IR), and in muscle tissues to hybrid insulin/ IGF1 receptors (IR/IGF1R) [7], promotes the autophosphorylation of a trio of regulatory loop tyrosine residues, disinhibiting IR tyrosine kinase activity toward IRS [8].”
BackgroundGreenberg, A. S., Shen, W., Muliro, K. V., Patel, S., Souza, S. C., Roth, R. A., & Kraemer, F. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104436200 · Cited by 363 · cited 1× · see citing works
“Potentially contributing to the latter finding, ERK1/2 can promote lipolysis and NEFA-mediated insulin resistance, both by downregulating adipocyte perilipin [120] and activating hormone-sensitive lipase [121].”
BackgroundProtein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101
Li, Y., Soos, T. J., Li, X., Wu, J., DeGennaro, M., Sun, X., Littman, D. R., Birnbaum, M. J., & Polakiewicz, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400186200 · Cited by 358 · cited 3× · see citing works
“Of these, phospho-S312, -S616, -S636 and -S1101 are associated with desensitisation of insulin signalling (above and [56, 65]), whereas phospho-S1223 has a sensitising effect [31].”
BackgroundJNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347 · cited 23× · see citing works
“Solinas G, Karin M. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction.”
BackgroundInfluentialmTOR couples cellular nutrient sensing to organismal metabolic homeostasis
Howell, J. J., & Manning, B. D. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.12.003 · Cited by 333 · cited 2× · see citing works
“Nonetheless, mTORC1/S6K can be stimulated by nutrients independently of IRS [107]—most clearly by branched-chain amino acids (BCAA) such as leucine [108].”
BackgroundRothman, D. L., Magnusson, I., Cline, G., Gerard, D., Kahn, C. R., Shulman, R. G., & Shulman, G. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.983 · Cited by 325 · cited 1× · see citing works
“Related studies show that decreased muscle glucose transport via the GLUT4 path underlies this alteration [74, 77].”
BackgroundStructure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor
Eck, M. J., Dhe‐Paganon, S., Trüb, T., Nolte, R. T., & Shoelson, S. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81236-2 · Cited by 323 · cited 1× · see citing works
“The PH domain is the principal module that links IRS1 with the activated IR [26], whereas the PTB domain enhances this interaction via binding to the phospho-NPEY motif within the IR juxtamembrane region [27].”
BackgroundBouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J.-P., Laville, M., Le Marchand-Brustel, Y., Tanti, J.-F., & Vidal, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1319 · Cited by 305 · see citing works
Zhang, J., Gao, Z., Yin, J., Quon, M. J., & Ye, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806480200 · Cited by 297 · cited 3× · see citing works
“Notably, in mouse embryonic fibroblasts, IKKβ is required for TNFα-stimulated phosphorylation of IRS1 S265; mutation of this residue in HEK293 cells (hS270) reduces TNFα stimulation of IRS1–S6K interaction and other IRS1 phospho-S/T elevated in adipose tissue from ob/ob mice [55].”
BackgroundPlasma immunoreactive endothelin in essential hypertension
Kohno, M., Yasunari, K., Murakawa, K., Yokokawa, K., Horio, T., Fukui, T., & Takeda, T. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90527-k · Cited by 291 · cited 1× · see citing works
“Increased plasma concentration of the vasoconstrictive ET-1 polypeptide is associated with insulin resistance and/or hypertension [128, 129], which is, in turn, promoted by direct and indirect (sympathoadrenal and angiotensin II-dependent) effects of compensatory hyperinsulinaemia to cause sodium retention (reviewed i…”
BackgroundÖst, A., Svensson, K., Ruishalme, I., Brännmark, C., Franck, N., Krook, H., Sandström, P., Kjølhede, P., & Strålfors, P. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00023 · Cited by 271 · cited 2× · see citing works
“upstream insulin resistance), the implication is that mTORC1 activity is reduced in insulinresistant human adipocytes in vivo [116].”
BackgroundMacotela, Y., Emanuelli, B., Bång, A. M., Espinoza, D., Boucher, J., Beebe, K. D., Gall, W., & Kahn, C. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021187 · Cited by 263 · cited 1× · see citing works
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundGao, Z., Zuberi, A. R., Quon, M. J., Dong, Z., & Ye, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300423200 · Cited by 258 · cited 1× · see citing works
“AKT may also phosphorylate S267 (hS272) in TNFα-treated cells [105].”
BackgroundMothe‐Satney, I., & OBBERGHEN, E. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11222 · Cited by 255 · cited 1× · see citing works
“For example, the simultaneous mutation to alanine of four S/Ts near IRS1 YXXMs (mS612/632/662/731A; hS616/636/ 666/736A) was shown to increase basal and insulinstimulated IRS1 tyrosine phosphorylation and associated PI3K activity [33].”
BackgroundInsulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302
Werner, E. D., Lee, J., Hansen, L., Yuan, M., & Shoelson, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405203200 · Cited by 252 · see citing works
Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M., & Kobayashi, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5050-5062.2001 · Cited by 249 · cited 2× · see citing works
“Prior treatment with proteasome inhibitors can block the insulin-induced degradation of IRS1, but not its intracellular transit or the desensitisation of downstream signalling and glucose uptake [48].”
BackgroundFea, K. D., & Roth, R. A. (1997) · Biochemistry · doi:10.1021/bi971157f · Cited by 246 · cited 1× · see citing works
“Mutation of S612 is sufficient to protect HEK293 cells against the desensitisation of insulin signalling by phorbol 12-myristate 13-acetate (PMA)-activated novel and conventional PKC (cPKC) isoforms [155].”
BackgroundAlterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans
Fröjdö, S., Vidal, H., & Pirola, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.019 · Cited by 242 · cited 6× · see citing works
“Any regulatory effects of AKT-mediated IRS phosphorylation are obscured in knockout mice by the necessity of AKT2 for downstream signalling [22]; however, less complete impairment of AKT activity, such as that observed in diabetic muscle, might have a partial homeostatic effect, by reducing inhibitory feedback via dow…”
BackgroundResultInfluentialJakobsen, S. N., Hardie, D. G., Morrice, N., & Tornqvist, H. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100483200 · Cited by 238 · cited 1× · see citing works
“Interestingly, treatment of C2C12 muscle cells with the AMPK agonist 5-aminoimidazole-4carboxamide-1-β-D-ribofuranoside (AICAR) has an additive effect, with insulin, to promote IRS1-associated PI3K activity [145].”
BackgroundThe Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man
Krebs, M., Brunmair, B., Brehm, A., Artwohl, M., Szendroedi, J., Nowotny, P., Roth, E., Fürnsinn, C., Promintzer, M., Anderwald, C., et al. (2007) · Diabetes · doi:10.2337/db06-1016 · Cited by 230 · cited 1× · see citing works
“Similar human studies demonstrate the involvement of mTORC1 in these effects [114], as well as the stimulation by AA of IRS1 S1101 (mS1097) phosphorylation in muscle, likely by S6K1 [56].”
BackgroundXu, X., Sarikas, A., Dias-Santagata, D. C., Dolios, G., Lafontant, P. J., Tsai, S.-C., Zhu, W., Nakajima, H., Nakajima, H. O., Field, L. J., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.009 · Cited by 218 · cited 1× · see citing works
“522–574 of (mouse) IRS1 are required for its ubiquitination and degradation via the cullin 7 E3 ligase [66].”
BackgroundRavichandran, L. V., Esposito, D. L., Chen, J. Y. ‐., & Quon, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007231200 · Cited by 217 · cited 1× · see citing works
“In contrast, in Fao or NIH3T3 cells stably expressing IR, overexpression of PKCζ enhances the dissociation from IR and decrease in IRS1 tyrosine phosphorylation caused by prolonged insulin stimulation [95, 96].”
BackgroundEssential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation
Miki, H., Yamauchi, T., Suzuki, R., Komeda, K., Tsuchida, A., Kubota, N., Terauchi, Y., Kamon, J., Kaburagi, Y., Matsui, J., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2521-2532.2001 · Cited by 214 · cited 1× · see citing works
“in all tissues, exhibit abnormal or severely compromised adipocyte differentiation [16, 17].”
BackgroundBandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210 · cited 2× · see citing works
“Increased basal phosphorylation of a few IRS S/T—S312 [87], S323 [60], and S636 [91] (mS307, mS318, mS632)—has been described in muscle of type 2 diabetic individuals, whereas basal and stimulated phosphorylation of S330 (mS325) is specifically decreased in muscle of obese insulin-resistant individuals [60].”
BackgroundAndreozzi, F., Laratta, E., Sciacqua, A., Perticone, F., & Sesti, G. (2004) · Circulation Research · doi:10.1161/01.res.0000126501.34994.96 · Cited by 208 · cited 1× · see citing works
“Conversely, increased ERK1/2 phosphorylation of mS612/hS616 is associated with angiotensin II-mediated impairment of endothelial nitric oxide synthase activation (by AKT) in vascular endothelial cells [124].”
BackgroundGreene, M. W., Sakaue, H., Wang, L., Alessi, D. R., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209153200 · Cited by 201 · cited 1× · see citing works
“Counter to this idea, the mutation of mS307 to alanine in cultured cells has a rapamycin-like effect, in that it blocks IRS1 disappearance during prolonged insulin stimulation [51, 52]; however, it is not shown that S307A mutation alone alters IRS1 localisation and/or PI3K signalling in these studies.”
BackgroundTargets for TNF-α-induced lipolysis in human adipocytes
Rydén, M., Nordström, E. A., Blomqvist, L., Perbeck, L. G., Dicker, A., & Arner, P. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.010 · Cited by 200 · cited 1× · see citing works
“Potentially contributing to the latter finding, ERK1/2 can promote lipolysis and NEFA-mediated insulin resistance, both by downregulating adipocyte perilipin [120] and activating hormone-sensitive lipase [121].”
BackgroundIrs1 Serine 307 Promotes Insulin Sensitivity in Mice
Copps, K. D., Hançer, N. J., Opare-Ado, L., Qiu, W., Walsh, C., & White, M. F. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.003 · Cited by 196 · cited 1× · see citing works
“In contrast, we used genetic knock-in to replace wild-type IRS1 in mice with a mutant form (S307A, ‘A’) lacking the ability to be phosphorylated at S307 (hS312) [171].”
MethodSelf-citationRabøl, R., Petersen, K. F., Dufour, S., Flannery, C. A., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110105108 · Cited by 195 · cited 1× · see citing works
“Frequent sampling of postprandial blood in these individuals—in combination with more sophisticated tracer/ imaging techniques to monitor metabolism—reveals the redirection of dietary carbohydrate away from glycogen synthesis in muscle and toward the insulin-driven synthesis of TAG in the liver [75, 76].”
BackgroundPaz, K., Liu, Y., Shorer, H., Hemi, R., LeRoith, D., Quan, M., Kanety, H., Seger, R., & Zick, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28816 · Cited by 191 · cited 1× · see citing works
“AKT—In contrast to PKCλ, overexpression of membrane-localised AKT (in CHO-T cells) promotes retention of IRS1 tyrosine phosphorylation during prolonged insulin stimulation (after 1 h), with no effect on its acute phosphor-ylation (after 2 min) [104].”
BackgroundLong, Y.-C., Cheng, Z.-Y., Copps, K. D., & White, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-10 · Cited by 186 · cited 2× · see citing works
“IRS-deficient muscles also undergo atrophy, with impaired phosphorylation of S6K and its substrate, ribosomal S6 protein [14].”
BackgroundSelf-citationFarese, R. V., Sajan, M. P., & Standaert, M. L. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523000901 · Cited by 185 · cited 2× · see citing works
“signalling is pleiotropic, combined defects in AKT- and aPKC-promoted muscle glucose uptake might be key in the initiation of metabolic disease [23].”
BackgroundWhelan, S. A., Dias, W. B., Thiruneelakantapillai, L., Lane, M. D., & Hart, G. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077818 · Cited by 185 · cited 1× · see citing works
“910–1037) or elsewhere can also impair IRS1–PI3K interaction [63, 64].”
BackgroundShah, O. J., & Hunter, T. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01254-05 · Cited by 178 · cited 8× · see citing works
“Yet S302 phosphorylation is implicated in the degradation of IRS1 caused by excessive mTORC1→S6K1 activation [51].”
BackgroundInfluentialTemporal Dynamics of Tyrosine Phosphorylation in Insulin Signaling
Schmelzle, K., Kane, S., Gridley, S., Lienhard, G. E., & White, F. M. (2006) · Diabetes · doi:10.2337/db06-0148 · Cited by 178 · cited 1× · see citing works
“Although IR phosphorylates numerous other proteins [9], work with knockout mice has revealed that many insulin responses, including the regulation of carbohydrate and lipid metabolism, require IRS1 and IRS2 [10].”
BackgroundThe Pleckstrin Homology Domain Is the Principle Link between the Insulin Receptor and IRS-1
Yenush, L., Makati, K. J., Smith-Hall, J., Ishibashi, O., Myers, M. G., & White, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24300 · Cited by 173 · cited 1× · see citing works
“The PH domain is the principal module that links IRS1 with the activated IR [26], whereas the PTB domain enhances this interaction via binding to the phospho-NPEY motif within the IR juxtamembrane region [27].”
BackgroundSelf-citationRole of Rho-kinase in regulation of insulin action and glucose homeostasis
Furukawa, N., Ongusaha, P. P., Jahng, W. J., Araki, K., Choi, C. S., Kim, H.-J., Lee, Y. H., Kaibuchi, K., Kahn, B. B., Masuzaki, H., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.011 · Cited by 173 · cited 14× · see citing works
“Some data suggest that ROCK1 inhibits, rather than promotes, IRS signalling [125], and it has not been demonstrated whether phosphomimetic mutation of mS632 and mS635 can overcome the negative effects of ROCK1 inhibition/knockdown.”
BackgroundInfluentialLaustsen, P. G., Russell, S. J., Cui, L., Entingh-Pearsall, A., Holzenberger, M., Liao, R., & Kahn, C. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01110-06 · Cited by 173 · see citing works
Luo, J., Field, S. J., Lee, J. Y., Engelman, J. A., & Cantley, L. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503088 · Cited by 172 · cited 1× · see citing works
“localisation in insulin-treated cells [57]; however, it remains unclear to what degree the active fraction is S/T phosphorylated.”
BackgroundG Alpha-q/11 Protein Plays a Key Role in Insulin-Induced Glucose Transport in 3T3-L1 Adipocytes
Imamura, T., Vollenweider, P., Egawa, K., Clodi, M., Ishibashi, K., Nakashima, N., Ugi, S., Adams, J. W., Brown, J. H., & Olefsky, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6765 · Cited by 172 · see citing works
cJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance
Sabio, G., & Davis, R. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.004 · Cited by 170 · cited 2× · see citing works
“By analogy with JNK1 activity, IRS1 S307 phosphorylation could also have mixed, tissue-specific effects that are obscured by the standard knock-in approach [166].”
BackgroundLiberman, Z., & Eldar-Finkelman, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410610200 · Cited by 170 · cited 1× · see citing works
“) Serine residues phosphorylated by GSK3 are typically primed by phosphorylation at a nearby site (SXXXS motif), and mutation of both S332 and S336 of IRS1 (hS337, hS341) to alanine enhances both basal and insulin-stimulated tyrosine phosphorylation of IRS1, as well as insulin-stimulated AKT activation in cultured cel…”
BackgroundFarese, R. V., Sajan, M. P., Yang, H., Li, P., Mastorides, S., Gower, W. R., Nimal, S., Choi, C. S., Kim, S., Shulman, G. I., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31408 · Cited by 169 · see citing works
Dynamics of Insulin Signaling in 3T3-L1 Adipocytes
Inoue, G., Cheatham, B., Emkey, R., & Kahn, C. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11548 · Cited by 168 · see citing works
Beeson, M., Sajan, M. P., Dizon, M. N., Grebenev, D., Gomez-Daspet, J., Miura, A., Kanoh, Y., Powe, J. L., Bandyopadhyay, G. K., Standaert, M. L., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1926 · Cited by 162 · cited 2× · see citing works
“Additionally, AKT S473 phosphorylationmay not fully reflect upstream IRS→PI3K signalling, as non-diabetic but glucose-intolerant individuals can show significantly impaired muscle aPKC activation [83].”
BackgroundHorike, N., Takemori, H., Katoh, Y., Doi, J., Min, L., Asano, T., Sun, X. J., Yamamoto, H., Kasayama, S., Muraoka, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211770200 · Cited by 161 · cited 1× · see citing works
“S789 of IRS1 when co-expressed in cells [143].”
BackgroundThe Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
Hanke, S., & Mann, M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800407-mcp200 · Cited by 160 · cited 1× · see citing works
“The tyrosines on IRS1 demonstrated by mutation or MS to recruit dimeric PI3K, GRB2 or SHP2 signalling proteins are indicated by the red bars [18, 178].”
BackgroundBegum, N., Sandu, O. A., Ito, M., Lohmann, S. M., & Smolenski, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110508200 · Cited by 159 · cited 1× · see citing works
“Some data suggest that ROCK1 inhibits, rather than promotes, IRS signalling [125], and it has not been demonstrated whether phosphomimetic mutation of mS632 and mS635 can overcome the negative effects of ROCK1 inhibition/knockdown.”
BackgroundInsulin signaling and glucose transport in insulin resistant human skeletal muscle
Karlsson, H. K. R., & Zierath, J. R. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0030-9 · Cited by 159 · cited 2× · see citing works
“Direct observations of human muscle do not support diminished IRS protein concentration as a primary cause of insulin resistance, though most studies have not examined IRS2 ([80, 81], and reviewed in [4]).”
BackgroundKnockout of PKCα Enhances Insulin Signaling Through PI3K
Letiges, M., Plomann, M., Standaert, M. L., Bandyopadhyay, G. K., Sajan, M. P., Kanoh, Y., & Farese, R. V. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0809 · Cited by 158 · see citing works
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation
Carlson, C. J., White, M. F., & Rondinone, C. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.082 · Cited by 155 · cited 1× · see citing works
“mTOR complex 1 (mTORC1) can mediate insulin- or anisomycin-stimulated S307 phosphor-ylation [41], casting some doubt on the significance of insulin-stimulated JNK phosphorylation of S307 observed in cultured cells [42].”
BackgroundSelf-citationPKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Bézy, O., Tran, T. T., Pihlajamäki, J., Suzuki, R., Emanuelli, B., Winnay, J., Mori, M. A., Haas, J. T., Biddinger, S. B., Leitges, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46045 · Cited by 148 · cited 4× · see citing works
“sensitivity and signalling, improves glucose tolerance, and reduces age-dependent hepatosteatosis [148].”
BackgroundInfluentialConsidine, R. V., Nyce, M. R., Allen, L. E., Morales, L. M., Triester, S., Serrano, J., Colberg, J., Lanza-Jacoby, S., & Caro, J. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118001 · Cited by 141 · cited 1× · see citing works
“skeletal muscle and liver tissues are characterised by increased PKCθ and PKCε levels, respectively [151, 152].”
BackgroundTzatsos, A., & Tsichlis, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610101200 · Cited by 140 · cited 1× · see citing works
“impairment of insulin-stimulated AKT activation caused by glucose deprivation [141].”
BackgroundWeigert, C., Hennige, A. M., Lehmann, R., Brodbeck, K., Baumgärtner, F., Schaüble, M., Häring, H. U., & Schleicher, E. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509782200 · Cited by 140 · cited 2× · see citing works
“PKCδ phosphorylation of S318/ hS323 and other residues may co-opt this chronic function to desensitise insulin signalling [99, 100, 103].”
BackgroundLiu, Y., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. R., Ohba, M., Kuroki, T., LeRoith, D., & Zick, Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.w118.003466 · Cited by 139 · see citing works
Yatabe, M., Yatabe, J., Yoneda, M., Watanabe, T., Otsuki, M., Felder, R. A., José, P. A., & Sanada, H. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29028 · Cited by 131 · cited 1× · see citing works
“Increased plasma concentration of the vasoconstrictive ET-1 polypeptide is associated with insulin resistance and/or hypertension [128, 129], which is, in turn, promoted by direct and indirect (sympathoadrenal and angiotensin II-dependent) effects of compensatory hyperinsulinaemia to cause sodium retention (reviewed i…”
BackgroundMoeschel, K., Beck, A., Weigert, C., Lammers, R., Kalbacher, H., Voelter, W., Schleicher, E. D., Häring, H., & Lehmann, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402477200 · Cited by 130 · cited 2× · see citing works
“Though S318A mutation aids retention of IRS1 tyrosine phosphor-ylation during prolonged stimulation, it impairs acute AKT S473 phosphorylation in skeletal muscle cells [101].”
BackgroundTargeted Disruption of ROCK1 Causes Insulin Resistance in Vivo
Lee, D. H., Shi, J., Jeoung, N. H., Kim, M., Zabolotny, J. M., Lee, S. W., White, M. F., Wei, L., & Kim, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c900014200 · Cited by 126 · cited 2× · see citing works
“There may also be a priming effect of S632 (hS636) phosphorylation by rho-associated coiled-coil containing protein kinase 1 (ROCK1) in mice [71, 72].”
BackgroundSelf-citationMorino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125 · cited 1× · see citing works
“Shulman and colleagues created transgenic mice with moderate overexpression in skeletal muscle (~twofold vs littermates) of nonmutant IRS1, or mutant IRS1 with alanine substitution of three serine residues—S302/307/612A (hS307/312/ 616A)—to block phosphorylation [170].”
BackgroundSelf-citationLiu, Y., Herschkovitz, A., Boura‐Halfon, S., Ronen, D., Paz, K., LeRoith, D., & Zick, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9668-9681.2004 · Cited by 124 · cited 1× · see citing works
“Similarly, mutation of S408 or S357 (hS413, hS362) at least partially blocks the desensitisation of insulin signalling by PKC pathways in PMA-treated cells [157, 158].”
BackgroundMdm2 is involved in the ubiquitination and degradation of G‐protein‐coupled receptor kinase 2
Salcedo, A., Mayor, F., & Penela, P. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601351 · Cited by 119 · cited 20× · see citing works
“ET-1 treatment of these cells reduces GLUT4 translocation, both by GRK2 kinase-independent effects on Gαq/11 (or IR), and by decreasing the level and tyrosine phosphorylation of IRS1 [126].”
BackgroundInfluentialWick, K. R., Werner, E. D., Langlais, P. R., Ramos, F. J., Dong, L., Shoelson, S. E., & Liu, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208518200 · Cited by 119 · cited 1× · see citing works
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphorylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulati…”
BackgroundPratipanawatr, W., Pratipanawatr, T., Cusi, K., Berria, R., Adams, J. M., Jenkinson, C. P., Maezono, K., DeFronzo, R. A., & Mandarino, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2572 · Cited by 118 · see citing works
Samuelsson, A., Bollano, E., Mobini, R., Larsson, B.-M., Ömerovic, E., Fu, M. L. X., Waagstein, F., & Holmäng, A. B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00974.2005 · Cited by 117 · cited 1× · see citing works
“In this light, it is notable that increased expression of type 1 angiotensin II receptors, promoted by experimental hyperinsulinaemia, correlates with increased IRS1 phosphor-ylation on mS369 [134].”
BackgroundTurban, S., & Hajduch, É. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.022 · Cited by 116 · cited 2× · see citing works
“) Activation of aPKCs by ceramide can contribute to insulin resistance in mice, though this appears to be due mostly to effects on AKT (reviewed in [94]).”
BackgroundAustin, R. L., Rune, A., Bouzakri, K., Zierath, J. R., & Krook, A. (2008) · Diabetes · doi:10.2337/db07-0763 · Cited by 105 · cited 3× · see citing works
“In another early study, TNFα—an inflammatory cytokine that can cause insulin resistance in healthy human muscle [34, 35]—was shown to stimulate multi-site S/T phosphorylation of IRS1 and IRS2, blocking their interaction with an IR juxtamembrane domain peptide [36].”
BackgroundQiao, L.-Y., Zhande, R., Jetton, T. L., Zhou, G., & Sun, X. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201494200 · Cited by 104 · see citing works
Increased protein kinase C theta in skeletal muscle of diabetic patients
Itani, S. I., Pories, W. J., MacDonald, K. G., & Dohm, G. L. (2001) · Metabolism · doi:10.1053/meta.2001.22512 · Cited by 101 · cited 1× · see citing works
“Diabetic skeletal muscle and liver tissues are characterised by increased PKCθ and PKCε levels, respectively [151, 152].”
BackgroundGiraud, J., Leshan, R. L., Lee, Y.-H., & White, M. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308631200 · Cited by 100 · cited 2× · see citing works
“However, mS302 (hS307) phosphorylation in cultured cells potentiates, rather than inhibits, downstream insulin signalling by IRS1 [73].”
BackgroundSelf-citationStructural and biochemical characterization of the KRLB region in insulin receptor substrate-2
Wu, J., Tseng, Y. D., Xu, C., Neubert, T. A., White, M. F., & Hubbard, S. R. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1388 · Cited by 98 · cited 3× · see citing works
“Abbreviations a.a. Amino acid residue AA Complex amino acid mixtures AMPK AMP-activated protein kinase aPKC Atypical protein kinase C cPKC Conventional protein kinase C ERK Extracellular signal-regulated kinase ET-1 Endothelin 1 GPCR G-protein coupled receptor GRB2 Growth factor receptor-bound protein 2 GRK2 G protein…”
BackgroundSelf-citationHennige, A. M., Stefan, N., Kapp, K., Lehmann, R., Weigert, C., Beck, A., Moeschel, K., Mushack, J., Schleicher, E. D., & Häring, H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4635fje · Cited by 94 · see citing works
Cipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., Trimarco, B., & Iaccarino, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp252 · Cited by 94 · cited 4× · see citing works
“While tissue GRK2 levels have been correlated with plasma norepinephrine/epinephrine levels [132], GRK2 can be upregulated in cultured cells by chronic insulin [89, 90], potentially as a result of PI3K-dependent stabilisation of GRK2 [133].”
BackgroundInfluentialUsui, I., Imamura, T., Satoh, H., Huang, J., Babendure, J. L., Hupfeld, C. J., & Olefsky, J. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600297 · Cited by 90 · cited 1× · see citing works
“GRK2 can additionally interfere directly with Gαq/11mediated signalling via its RGS (regulator of G protein signalling) domain/GAP activity [127].”
BackgroundDanielsson, A., Öst, A., Nyström, F. H., & Strålfors, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500230200 · Cited by 89 · cited 1× · see citing works
“Interestingly, insulin-stimulated phosphorylation of S307 (mS302) in human primary adipocytes correlates with donor insulin sensitivity [116] and is decreased in adipocytes of humans with type 2 diabetes [117].”
BackgroundModulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta
Greene, M. W., MORRICE, N. A., Garofalo, R. S., & Roth, R. A. (2004) · Biochemical Journal · doi:10.1042/bj20031493 · Cited by 89 · cited 2× · see citing works
“However, S302, S318 and S570 (hS307, hS323, hS574) are the major sites, and mutation of these residues alleviates inhibition of IRS1 tyrosine phosphorylation by IR in vitro [156].”
BackgroundGreene, M. W., & Garofalo, R. S. (2002) · Biochemistry · doi:10.1021/bi015992f · Cited by 88 · cited 2× · see citing works
“(However, dephosphorylation of basally present phospho-S/Ts is itself inhibitory vs no dephosphorylation [138].”
BackgroundKarlsson, H., Ahlsén, M., Zierath, J. R., Wallberg‐Henriksson, H., & Koistinen, H. A. (2006) · Diabetes · doi:10.2337/db05-0853 · Cited by 88 · cited 1× · see citing works
“aPKC signalling (and/or other steps in the muscle GLUT4 path) might be more sensitive to dysregulation than AKT, as one study found no difference vs control individuals in phosphorylation of AKT (S473) or AKTsubstrate of 160 kDa (AS160), despite the presence of impaired glucose disposal [84].”
BackgroundBard-Chapeau, E. A., Hevener, A. L., Long, S., Zhang, E. E., Olefsky, J. M., & Feng, G. (2005) · Nature Medicine · doi:10.1038/nm1227 · Cited by 88 · cited 2× · see citing works
“phospho-S612 (hS616) is clearly decreased [122].”
BackgroundClark, S. F., Molero, J.-C., & James, D. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3819 · Cited by 86 · cited 1× · see citing works
“For example, in 3T3L1 adipocytes, prolonged insulin stimulation causes transit of hyper-S/T-phosphorylated IRS1 from low-density membrane (LDM/high speed pellet) to the cytosol, and this can be inhibited by the mTORC1 inhibitor rapamycin [47, 48].”
BackgroundKlein, A., Berkaw, M. N., Buse, M. G., & Ball, L. E. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900207-mcp200 · Cited by 86 · cited 1× · see citing works
“910–1037) or elsewhere can also impair IRS1–PI3K interaction [63, 64].”
BackgroundInsulin signaling regulating genes: effect on T2DM and cardiovascular risk
Prudente, S., Morini, E., & Trischitta, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.215 · Cited by 85 · cited 1× · see citing works
“Interestingly, this region of IRS1 contains the human Gly972Arg polymorphism that in some studies is associated with type 2 diabetes risk [61] and might reduce Y941 or Y989 phosphorylation by disrupting an (unknown) IRS1 secondary structure [62].”
BackgroundStorgaard, H., Song, X. M., Jensen, C. B., Madsbad, S., Björnholm, M., Vaag, A. A., & Zierath, J. R. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2770 · Cited by 82 · see citing works
Usui, I., Imamura, T., Babendure, J. L., Satoh, H., Lu, J.-C., Hupfeld, C. J., & Olefsky, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0429 · Cited by 82 · see citing works
Kim, J., Yeh, D. C., Ver, M. R., Li, Y., Carranza, A., Conrads, T. P., Veenstra, T. D., Harrington, M. A., & Quon, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501439200 · Cited by 78 · see citing works
McGettrick, A., Feener, E. P., & Kahn, C. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412300200 · Cited by 78 · cited 1× · see citing works
“Interestingly, this region of IRS1 contains the human Gly972Arg polymorphism that in some studies is associated with type 2 diabetes risk [61] and might reduce Y941 or Y989 phosphorylation by disrupting an (unknown) IRS1 secondary structure [62].”
BackgroundIKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance
Hung (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000065 · Cited by 75 · cited 4× · see citing works
“Lee DF, Kuo HP, Chen CT, et al. IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance.”
BackgroundInfluentialMetabolic functions of atypical protein kinase C: “good” and “bad” as defined by nutritional status
Farese, R. V., & Sajan, M. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00608.2009 · Cited by 74 · cited 1× · see citing works
“(In human muscle, the PKCι orthologue of PKCλ appears to predominate [93].”
BackgroundTzatsos, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027748 · Cited by 74 · see citing works
Global IRS-1 phosphorylation analysis in insulin resistance
Langlais, P. R., Yi, Z., Finlayson, J., Luo, M., Mapes, R., Filippis, E. D., Meyer, C., Plummer, E., Tongchinsub, P., Mattern, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2271-9 · Cited by 71 · cited 11× · see citing works
“PKCδ phosphorylation of S318/ hS323 and other residues may co-opt this chronic function to desensitise insulin signalling [99, 100, 103].”
BackgroundInfluentialWeigert, C., Kron, M., Kalbacher, H., Pohl, A. K., Runge, H., Häring, H., Schleicher, E. D., & Lehmann, R. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0102 · Cited by 66 · cited 3× · see citing works
“Conversely, phosphomimetic mutation of S318 to glutamate (S318E) enhances early signalling [70].”
BackgroundTanak, H., & Yavuz, M. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-009-0539-5 · Cited by 66 · see citing works
Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer
Lü (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000291 · Cited by 65 · see citing works
Rincon, S. V. D., Guo, Q., Morelli, C., Shiu, H. Y., Surmacz, E., & Miller, W. H. (2004) · Oncogene · doi:10.1038/sj.onc.1208104 · Cited by 65 · cited 1× · see citing works
“PKCδ phosphorylation of S318/ hS323 and other residues may co-opt this chronic function to desensitise insulin signalling [99, 100, 103].”
BackgroundNakamori, Y., Emoto, M., Fukuda, N., Taguchi, A., Okuya, S., Tajiri, M., Miyagishi, M., Taira, K., Wada, Y., & Tanizawa, Y. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601065 · Cited by 65 · cited 1× · see citing works
“In 3T3L1 cells, TNFα-stimulated phosphorylation of mS307 is dependent upon the interaction of IRS1 with the NEMO/IKKγ subunit of the IĸB kinase complex, promoted by the actindirected motor protein MYO1C [168].”
BackgroundYi, Z., Langlais, P. R., Filippis, E. A. D., Luo, M., Flynn, C. R., Schroeder, S., Weintraub, S. T., Mapes, R., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-1355 · Cited by 64 · cited 2× · see citing works
“[59]), we emphasise that this regulatory function might be subverted/co-opted by diabetogenic factors—not excluding Copps and White Page 8”
BackgroundMethodLuo, M., Langlais, P. R., Yi, Z., Lefort, N., Filippis, E. A. D., Hwang, H., Christ-Roberts, C. Y., & Mandarino, L. J. (2007) · Endocrinology · doi:10.1210/en.2007-0049 · Cited by 63 · cited 20× · see citing works
“Regardless, defective muscle IRS1→PI3K→AKT signalling in lean normoglycaemic offspring of type 2 diabetics has been correlated with increased basal S/T phosphorylation of IRS1—including at mTORC1 sites S312 and S636 (mS307, mS632), and S616 (mS612) [85].”
BackgroundInfluentialLuo, M., Reyna, S. M., Wang, L., Yi, Z.-P., Carroll, C. A., Dong, L., Langlais, P. R., Weintraub, S. T., & Mandarino, L. J. (2005) · Endocrinology · doi:10.1210/en.2005-0260 · Cited by 58 · cited 3× · see citing works
“Of these, phospho-S312, -S616, -S636 and -S1101 are associated with desensitisation of insulin signalling (above and [56, 65]), whereas phospho-S1223 has a sensitising effect [31].”
BackgroundNawaratne, R., Gray, A., Jørgensen, C. H., Downes, C. P., Siddle, K., & Sethi, J. K. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0536 · Cited by 57 · cited 4× · see citing works
“S24, altering its membrane-binding properties in cultured cells [29] (Fig.”
InfluentialIn vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
Chun, K., Choi, K., Lee, D.-H., Jung, Y., Henry, R. R., Ciaraldi, T. P., & Kim, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00538.2010 · Cited by 53 · cited 2× · see citing works
“Insulin-stimulated ROCK1 activity is also decreased in muscle of obese diabetic humans, in conjunction with upregulation of its kinase inhibitor RhoE [88].”
BackgroundAnis, Y., Leshem, O., Reuveni, H., Wexler, I. D., Sasson, R. B., Yahalom, B., Laster, M., Raz, I., Sasson, S. B., Shafrir, E., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1444-1 · Cited by 52 · cited 1× · see citing works
“Importantly, and consistent with these data, GRK2-interfering peptides improve insulin sensitivity in diabetic animal models [137]; thus, GRK2 is a potential target for the treatment of insulin resistance.”
BackgroundAltered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2
Matsuo, K., Delibegović, M., Matsuo, I., Nagata, N., Liu, S., Bettaieb, A., Xi, Y., Araki, K., Yang, W., Kahn, B. B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153734 · Cited by 52 · cited 2× · see citing works
“IRS1 phospho-S307 (hS312) increases, contrary to the inhibitory function of S307 phosphorylation in cultured cells [25].”
BackgroundWeigert, C., Hennige, A. M., Brischmann, T., Beck, A., Moeschel, K., Schaüble, M., Brodbeck, K., Häring, H.-U., Schleicher, E. D., & Lehmann, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506134200 · Cited by 50 · cited 1× · see citing works
“Though S318A mutation aids retention of IRS1 tyrosine phosphor-ylation during prolonged stimulation, it impairs acute AKT S473 phosphorylation in skeletal muscle cells [101].”
BackgroundMüssig, K., Fiedler, H., Staiger, H., Weigert, C., Lehmann, R., Schleicher, E. D., & Häring, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.154 · Cited by 49 · cited 1× · see citing works
“Treatment of C2C12 cells with inhibitors implicates JNK and mTORC1 as additional insulin-stimulated S318 kinases [102], demonstrating that multiple pathways may”
BackgroundHuang, W., Bansode, R. R., Bal, N. C., Mehta, M., & Mehta, K. D. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m019687 · Cited by 47 · cited 1× · see citing works
“Knockout of the gene encoding PKCβ protects mice against high-fat diet induced obesity, insulin resistance, and hepatosteatosis, but might do so independently of effects on IRS [163].”
BackgroundTHE MOLECULAR BASIS OF INSULIN ACTION
G.Myers, J. A. M. F. W. M. (2002) · CRC Press eBooks · doi:10.1201/b12794-13 · Cited by 47 · see citing works
Das, F., Ghosh‐Choudhury, N., Dey, N., Mandal, C. C., Mahimainathan, L., Kasinath, B. S., Abboud, H. E., & Choudhury, G. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246397 · Cited by 43 · cited 2× · see citing works
“Related pathways that contribute to the regulation of AKT include: (1) mTORC1 phosphor-ylation/ stabilisation of GRB10 [174], which inhibits productive interaction of IRS with a key phosphotyrosine in IR [175]; (2) inhibition of mTORC2 by S6K1-mediated phosphorylation of rictor [176]; and (3) transcriptional upregulat…”
BackgroundOriente, F., Andreozzi, F., Romano, C., Perruolo, G., Perfetti, A., Fiory, F., Miele, C., Bèguinot, F., & Formisano, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508570200 · Cited by 43 · cited 1× · see citing works
“In contrast, prolonged insulin stimulation in cultured cells can increase PKCα binding to IRS1 in complex with 14-3-3ε [161].”
BackgroundWaraich, R. S., Weigert, C., Kalbacher, H., Hennige, A. M., Lutz, S. Z., Häring, H., Schleicher, E. D., Voelter, W., & Lehmann, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708588200 · Cited by 43 · cited 1× · see citing works
“Similarly, mutation of S408 or S357 (hS413, hS362) at least partially blocks the desensitisation of insulin signalling by PKC pathways in PMA-treated cells [157, 158].”
BackgroundCho, M., Rao, M. N., Koch, W. J., THOMAS, S. A., Palmiter, R. D., & Rockman, H. A. (1999) · Circulation · doi:10.1161/01.cir.99.20.2702 · Cited by 42 · cited 1× · see citing works
“While tissue GRK2 levels have been correlated with plasma norepinephrine/epinephrine levels [132], GRK2 can be upregulated in cultured cells by chronic insulin [89, 90], potentially as a result of PI3Kdependent stabilisation of GRK2 [133].”
BackgroundFritsche, L., Neukamm, S. S., Lehmann, R., Kremmer, E., Hennige, A. M., Hunder-Gugel, A., Schenk, M., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2010 · Cited by 40 · cited 1× · see citing works
“As far less is currently known about IRS2 S/T phosphorylation, we refer the reader to other, limited sources [5, 92].”
BackgroundShort-Term Overeating Induces Insulin Resistance in Fat Cells in Lean Human Subjects
Danielsson, A., Fagerholm, S., Öst, A., Franck, N., Kjølhede, P., Nyström, F. H., & Strålfors, P. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00037 · Cited by 40 · cited 1× · see citing works
“ERK1/2 activation is also sensitised to insulin in adipocytes from humans fed a highenergy diet, potentially contributing to the adaptive expansion of adipose tissue [119].”
BackgroundPhosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling
Giraud, J., Haas, M., Feener, E. P., Copps, K. D., Dong, X. C., Dunn, S. L., & White, M. F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0159 · Cited by 38 · cited 1× · see citing works
“We have shown that insulin-stimulated S522 phosphorylation—which is inhibited by small interfering RNA against AKT—impairs IRS1 tyrosine phosphorylation and PI3K binding in HEK293 cells [58].”
BackgroundSelf-citationKnockout of PKC Enhances Insulin Signaling Through PI3K
Letiges, M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.847 · Cited by 37 · see citing works
Mack, E., Ziv, E., Reuveni, H., Kalman, R., Niv, M. Y., Jörns, A., Lenzen, S., & Shafrir, E. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.881 · Cited by 36 · cited 1× · see citing works
“Rodent and human studies validate the contribution of dyslipidaemia to skeletal muscle and liver insulin resistance via diacylglycerol-mediated activation of nPKCs, including PKCθ [65, 146, 147], PKCδ [148] and PKCε [149, 150] (reviewed in [74, 94]).”
BackgroundGRK2 Negatively Regulates Glycogen Synthesis in Mouse Liver FL83B Cells
Shahid, G., & Hussain, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700744200 · Cited by 34 · cited 1× · see citing works
“In FL83B mouse liver cells, glycogen synthesis is upregulated by GRK2 knockdown, and this is associated with decreased basal and insulinstimulated IRS1 S307 (hS312) phosphorylation [136].”
BackgroundLiberman, Z., Plotkin, B., Tennenbaum, T., & Eldar-Finkelman, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00050.2008 · Cited by 32 · cited 1× · see citing works
“PKCβ2 can phosphorylate IRS1 on mS336/hS341 in vitro, suggesting it is a priming kinase for GSK3 phosphorylation of IRS1 [162].”
BackgroundSommerfeld, M. R., Metzger, S. U., Stosik, M., Tennagels, N., & Eckel, J. (2004) · Biochemistry · doi:10.1021/bi049640v · Cited by 30 · cited 1× · see citing works
“However, PKCζ can phosphorylate IRS1 in vitro on S498, S570 and S612 (hS503, hS574, hS616), with phospho-S570 having an adverse effect on PI3K binding [98].”
BackgroundKatsnelson, A. (2011) · Nature Medicine · doi:10.1038/nm1211-1536 · Cited by 20 · see citing works
Downregulation of Grb2 contributes to the insulin-sensitizing effect of calorie restriction
Liu, X., Liu, M., Zhang, J., Bai, X. S., Ramos, F. J., Remmen, H. V., Richardson, A. G., Liu, F., Dong, L., & Liu, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90714.2008 · Cited by 19 · cited 1× · see citing works
“conjunction with increased AKT activation [123].”
Protein kinase Cα regulates insulin receptor signaling in skeletal muscle
Cipok, M., Aga‐Mizrachi, S., Bak, A., Feurstein, T., Steinhart, R., Brodie, C., & Sampson, S. R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.008 · Cited by 18 · cited 1× · see citing works
“PKCα in rodent muscle associates basally with IRS1; insulin transiently disrupts this interaction while increasing PKCα association with AKT [160].”
BackgroundBoura‐Halfon, S., Shuster-Meiseles, T., Beck, A., Petrovich, K., Gurevitch, D., Ronen, D., & Zick, Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0072 · Cited by 11 · cited 4× · see citing works
“Potentially then, the disruptive effect of S307 phosphorylation might be an assay- or condition-dependent aspect of a more generalised S/T phosphorylation-based mechanism governing IRS signalling [5, 45, 46].”
BackgroundInfluentialFischman (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000262 · Cited by 6 · cited 1× · see citing works
“Compatible with regulated ubiquitin/proteasomal processing of IRS1, exposure of HEK293 cells to very high insulin showed that about 50% of total IRS1 could be degraded within 10 min via internal cleavage around hS475 or hS641; however, the necessary factors were not investigated [67].”
BackgroundIκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin signalling cascade
Lancaster, G. I., Skiba, B., Yang, C., Nicholls, H. T., Langley, K. G., Chan, S. M. H., Bruce, C. R., Rewcastle, G. W., Shepherd, P. R., Karin, M., et al. (2011) · Biochemical Journal · doi:10.1042/bj20112037 · Cited by 5 · cited 2× · see citing works
“IRS1 tyrosine phosphorylation/PI3K activity or glucose uptake [169].”
BackgroundThe Mechanisms of Insulin Action
White, M. F., Copps, K. D., Özcan, U., & Tseng, Y. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00034-4 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
2 of the 185 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · see citing works
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611 · see citing works
Diabetes mellitus: The epidemic of the century
Kharroubi, A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,270 · see citing works
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258 · see citing works
Insulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929 · see citing works
“This process creates a suitable binding site for IRS‐1 that is then activated via phosphorylation by different insulin‐induced kinases such as PKC, SIK2, AKT, S6K1, mTOR, extracellular signal‐regulated kinase 1/2 (ERK1/2), and ROCK1 (Copps & White, 2012; Kiselyov et al., 2009).”
BackgroundAdvanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G. A., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 931 · see citing works
“A plethora of evidence suggests AGEs/RAGE signaling pathway, NFκB activation, inflammation, and ROS generation are directly related to the pathogenesis of insulin resistance by increased IRS-1serine phosphorylation and degradation, thus blocking the insulin signaling pathway [68,71,73,74].”
BackgroundBiochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · see citing works
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 786 · see citing works
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 701 · see citing works
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8609213 · Cited by 689 · see citing works
“Several types of insulin-dependent kinases such as ERK1/2 (extracellular signal-regulated kinase 1/2), atypical PKC (protein kinase C), S6K1 (ribosomal protein S6 kinase beta-1), SIK2 (serine/threonine-protein kinase 2), Akt (protein kinase B), mTOR (mammalian target of rapamycin), and ROCK1 (rho-associated protein ki…”
BackgroundMetabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 681 · see citing works
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Shorning, B. Y., Dass, M. S., Smalley, M. J., & Pearson, H. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124507 · Cited by 638 · see citing works
“In addition, mTORC1 signaling can negatively regulate RTK signaling to reduce both PI3K-AKT-mTOR and RAS/MAPK activity, including mTORC1-S6K-mediated suppression of the insulin receptor substrate protein IRS1; a major IGF-1 receptor substrate and adaptor protein that can promote both PI3K and RAS activation by binding…”
BackgroundGuo, S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 625 · see citing works
“IRS proteins are characterized by the presence of a NH2-terminal pleckstrin homology (PH) domain adjacent to a phosphotyrosine-binding (PTB) domain, followed by a COOH-terminal tail that contains numerous tyrosine and serine/threonine phosphorylation sites (Copps & White 2012).”
BackgroundThe crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 630 · see citing works
“residues phosphorylation in the IRS and desensitization of proximal insulin signaling plays an important role in the pathogenesis of IR (127).”
BackgroundEmerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Üstünel, B. E. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 544 · see citing works
Foundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamışlıgil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 515 · see citing works
Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease
Chadt, A., & Al-Hasani, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02417-x · Cited by 510 · see citing works
“Mechanistically, HCV core protein leads to upregulation of inflammatory markers such as tumor necrosis factor α (TNF-α), eventually resulting in reduced downstream activation of insulin signaling [36].”
BackgroundCell Signaling and Stress ResponsesPreprint
Hotamışlıgil, G. S., & Davis, R. J. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006072 · Cited by 496 · see citing works
Blázquez, E., Velázquez, E., Hurtado-Carneiro, V., & Ruiz-Albusac, J. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00161 · Cited by 502 · see citing works
“As only phospho-Ser/Thr on IRS-1 can have negative or positive effects on the insulin signaling of healthy and diseased tissues, those molecules might play an important pathophysiological role (292).”
BackgroundInflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532 · see citing works
GSK3 and its interactions with the PI3K/AKT/mTOR signalling network
Hermida, M. A., Kumar, J. D., & Leslie, N. R. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.003 · Cited by 480 · see citing works
“…feedback within individual systems, these events seem likely to act in cell types under different conditions (Carracedo and Pandolfi, 2008; Copps and White, 2012 One simple direct analysis of feedback between GSK3 and AKT was by a human kinome siRNA knockdown screen looking for kinases…”
BackgroundThe cell biology of systemic insulin function
Tokarz, V. L., MacDonald, P. E., & Klip, A. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201802095 · Cited by 471 · see citing works
“…autophosphorylation by inducing structural rearrangement of the transmembrane domains to bring them into close proximity with each other (Gutmann et al., 2018), and the consequent activation of the IR tyrosine kinase toward phosphorylation of its major substrates IRS1,2 (Copps and White, 2012).”
BackgroundThe impact of insulin resistance on the kidney and vasculature
Artunç, F., Schleicher, E. D., Weigert, C., Fritsche, A., Stefan, N., & Häring, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 474 · see citing works
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 452 · see citing works
40 YEARS OF IGF1: IGF1 receptor signaling pathways
Hakuno, F., & Takahashi, S. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0311 · Cited by 452 · see citing works
Metabolic Inflexibility: When Mitochondrial Indecision Leads to Metabolic Gridlock
Muoio, D. M. (2014) · Cell · doi:10.1016/j.cell.2014.11.034 · Cited by 438 · see citing works
Metabolic Messengers: tumour necrosis factor
Sethi, J. K., & Hotamışlıgil, G. S. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00470-z · Cited by 426 · see citing works
Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
Gabbouj, S., Ryhänen, S., Marttinen, M., Wittrahm, R., Takalo, M., Kemppainen, S., Martiskainen, H., Tanila, H., Haapasalo, A., Hiltunen, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00629 · Cited by 401 · see citing works
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Nielsen, T. S., Jessen, N., Jørgensen, J. O. L., Møller, N., & Lund, S. A. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0277 · Cited by 380 · see citing works
“When present in excess, several of these lipid intermediates have been suggested to induce insulin resistance in ectopic tissues by interfering with insulin signaling at the level of the insulin receptor substrate (IRS) proteins (Boura-Halfon & Zick 2009, Copps & White 2012).”
The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia
Sylow, L., Tokarz, V. L., Richter, E. A., & Klip, A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.020 · Cited by 366 · see citing works
Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Catrysse, L., & van Loo, G. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.006 · Cited by 329 · see citing works
“These proteins are tightly regulated by phosphorylation on both positive tyrosine and inhibitory serine/threonine residues [24].”
Kapogiannis, D., Boxer, A. L., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U. B., Frassetto, L. A., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2014) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345 · see citing works
Fecal microbiota transplantation in metabolic syndrome: History, present and future
de Groot, P. F., Frissen, M. N., de Clercq, N. C., & Nieuwdorp, M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1293224 · Cited by 322 · see citing works
“JNK changes the function of insulin receptor substrate 1 (IRS-1), which regulates insulin and insulin-like growth factor pathways.(45) These pathways play an important role in age-related disease and life span in animal models.”
BackgroundThe role of mammalian target of rapamycin (mTOR) in insulin signaling
Yoon, M.-S. (2017) · Nutrients · doi:10.3390/nu9111176 · Cited by 300 · see citing works
“Serine/threonine phosphorylation of IRS affects its tyrosine dephosphorylation, its dissociation from IR, its intracellular localization, and its eventual degradation in a proteasome dependent manner through the different mechanisms [58,75,76].”
BackgroundInfluentialBile acids are nutrient signaling hormones
Zhou, H., & Hylemon, P. B. (2014) · Steroids · doi:10.1016/j.steroids.2014.04.016 · Cited by 285 · see citing works
“TNFα inhibit insulin signaling by activation of the JNK 1/2 signaling pathway which phosphorylates insulin receptor substrate 1 (70).”
Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260 · see citing works
MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids
Fu, X., Dong, B., Tian, Y., Lefèbvre, P., Meng, Z., Wang, X., Pattou, F. N., Han, W., Wang, X., Lou, F., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75438 · Cited by 249 · see citing works
“Although many genetic and physiological factors interact to produce and aggravate insulin resistance, a common underlying mechanism is dysregulated insulin signaling by insulin receptor substrates (IRS1 and IRS2) that are inappropriately phosphorylated on serine residues (1).”
Metabolic functions of glucocorticoid receptor in skeletal muscle
Kuo, T., Harris, C. A., & Wang, J.-C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.003 · Cited by 240 · see citing works
“IRS-1 serine 307 mutated to alanine had reduced insulin sensitivity (Copps et al., 2010; Copps and White, 2012).”
BackgroundImplication of inflammatory signaling pathways in obesity-induced insulin resistance
Tanti, J., Ceppo, F., Jager, J., & Berthou, F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00181 · Cited by 241 · see citing works
“In physiological condition, insulin induces a time-controlled phosphorylation of both positive and inhibitory serine sites in IRS1 and IRS2 in order to ensure the fine tuning of IRS tyrosine phosphorylation that is necessary for the propagation of insulin action (Tanti and Jager, 2009; Copps and White, 2012).”
BackgroundNAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
Marušić, M., Paić, M., Knobloch, M., & Pršo, A.-M. L. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6613827 · Cited by 240 · see citing works
Insulin signalling and GLUT4 trafficking in insulin resistance
van Gerwen, J., Shun-Shion, A. S., & Fazakerley, D. J. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221066 · Cited by 233 · see citing works
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 234 · see citing works
“ERK proteins are one of the best-characterized groups of proteins able to phosphorylate IRSs [35,36].”
BackgroundInfluentialThe PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?
Razani, E., Pourbagheri‐Sigaroodi, A., Safaroghli‐Azar, A., Zoghi, A., Bavarsad, M. S., & Bashash, D. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01231-3 · Cited by 229 · see citing works
“The phosphorylated receptor then activates insulin receptor substrate (IRS) proteins at Tyr residue, which subsequently binds to the SH2 domain of the regulatory subunit of PI3K leading to its departure from the catalytic subunit (Copps and White 2012).”
BackgroundNewsholme, P., Keane, K. N., Carlessi, R., & Cruzat, V. F. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00141.2019 · Cited by 226 · see citing works
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 217 · see citing works
“…for establishing pathogenic feed-forward loops that inhibit normal insulin signaling, as mTORc, ribosomal protein S6 kinase beta-1 (S6K1), and GSK3-β induce hyperphosphorylation at various Ser residues (S632, S302/S522 and S337, respectively; EldarFinkelman and Krebs, 1997; Copps and White, 2012).”
BackgroundInsulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 214 · see citing works
“IRS proteins also contain >50 serine/ threonine phosphorylation sites (shown as red diamonds in Figure 2), which modulate stability and tyrosine phosphorylation for feedback and heterologous regulation [23].”
BackgroundInfluentialSelf-citationTau deletion promotes brain insulin resistance
Marciniak, E., Leboucher, A., Caron, E., Ahmed, T., Tailleux, A., Dumont, J., Issad, T., Gerhardt, E., Pagesy, P., Vileno, M., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161731 · Cited by 205 · see citing works
Nandipati, K. C., Subramanian, S., & Agrawal, D. K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2878-8 · Cited by 210 · see citing works
“In muscle of obese diabetic human subjects, insulin-stimulated ROCK1 was noticed to be decreased with up-regulation of its kinase inhibitor RhoE [144].”
BackgroundInsulin Signal Transduction Perturbations in Insulin Resistance
Khalid, M., Alkaabi, J., Khan, M. A. B., & Adem, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168590 · Cited by 233 · see citing works
“The tail of IRS1 contains distinct tyrosine and serine phosphorylation sites, which serve as the docking locus for SH2 homology signal transducers [20,46].”
BackgroundDefining the underlying defect in insulin action in type 2 diabetes
Batista, T. M., Haider, N., & Kahn, C. R. (2021) · Diabetologia · doi:10.1007/s00125-021-05415-5 · Cited by 204 · see citing works
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Ardestani, A. D., Lupše, B., Kido, Y., Leibowitz, G., & Maedler, K. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.004 · Cited by 194 · see citing works
“…via the phosphorylation of several key serine residues (such as mouse S265/S302/S522/S1097, human S270/S307/ S527/S1101 by S6K1, mouse S307/S612/S632, and human S312/S616/S636 by mTORC1) found by in vitro kinase assays and/or mutation studies in cells and mice (reviewed in Copps and White, 2012).”
BackgroundHomeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
Chao, H., Chao, S.-W., Lin, H., Ku, H., & Cheng, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020298 · Cited by 183 · see citing works
“Most of the insulin-mediated metabolic actions are controlled by the PI3K–AKT/PKB pathway, which is phosphorylated by the insulin receptor through two major substrates, IRS-1 and IRS-2 [34].”
BackgroundThe PI3K/Akt/PTEN/mTOR Pathway: A Fruitful Target for Inducing Cell Death in Rheumatoid Arthritis?
Malemud, C. J. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.55 · Cited by 174 · see citing works
Barone, E., Domenico, F. D., Perluigi, M., & Butterfield, D. (2021) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2021.09.006 · Cited by 155 · see citing works
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer
Jeong, S., Kim, H.-B., Kim, M., Lee, J.-M., Lee, J. H., Kim, J., Kim, J. W., Park, W., Kim, S., Kim, J. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95802 · Cited by 173 · see citing works
The interplay of factors in metabolic syndrome: understanding its roots and complexity
Islam, M. S., Wei, P., Suzauddula, M., Nime, I., Feroz, F., Acharjee, M., & Pan, F. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01019-y · Cited by 171 · see citing works
Qi, Y., Xu, Z., Zhu, Q., Thomas, C., Kumar, R., Feng, H., Dostal, D. E., White, M. F., Baker, K. M., & Guo, S. (2013) · Diabetes · doi:10.2337/db13-0095 · Cited by 167 · see citing works
“IRS1 and IRS2 serine or threonine phosphorylation is believed to mediate IRS degradation, ubiquitination, and insulin resistance (25).”
BackgroundSelf-citationXie, W., Ma, L. L., Xu, Y., Wang, B. H., & Li, S. M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.018 · Cited by 167 · see citing works
Petrov, D., Pedrós, I., Artiach, G., Sureda, F. X., Barroso, E., Pallàs, M., Casadesús, G., Beas-Zarate, C., Carro, E., Ferrer, I., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.004 · Cited by 163 · see citing works
“Unlike Tyr phosphorylation by the IR, which activates IRS, modifications at Ser/Thr residues are capable of both promoting and inhibiting downstream IRS-mediated signaling [57].”
InfluentialKumar, V., Xin, X., Ma, J., Tan, C., Osna, N. A., & Mahato, R. I. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113888 · Cited by 160 · see citing works
Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus
Hum, J., Jou, J. H., Green, P. K., Berry, K., Lundblad, J. R., Hettinger, B. D., Chang, M. F., & Ioannou, G. N. (2017) · Diabetes Care · doi:10.2337/dc17-0485 · Cited by 159 · see citing works
Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
Bayeva, M., Sawicki, K. T., & Ardehali, H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000433 · Cited by 156 · see citing works
“However, phosphorylation of residues adjacent to the PI3K binding sites by serine kinases displaces PI3K and thus interferes with its ability to activate IRS1.(90,94) The inhibitory effect of free FAs on IRS1 and insulin signaling was demonstrated in cell culture,(95,96) animal models, and human volunteers(100) and ma…”
BackgroundGalicia-Garcia, U., Jebari, S., Larrea-Sebal, A., Uribe, K., Siddiqi, H., Ostolaza, H., Benito-Vicente, A., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134725 · Cited by 141 · see citing works
“The downstream events that follow INSR activation include recruitment of several adaptor proteins, facilitating a suitable binding site for insulin receptor substrates (IRSs) [82] that once phosphorylated, trigger several downstream signals [83].”
BackgroundSin, T. K., Yung, B. Y., & Siu, P. M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369718 · Cited by 141 · see citing works
Antidiabetic potential of dietary polyphenols: A mechanistic review
Farias, D. D. P., de Araújo, F. F., Neri-Numa, I. A., & Pastore, G. M. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110383 · Cited by 149 · see citing works
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Bringas-Vega, M. L., García-del-Barco-Herrera, D., Berlanga-Saez, J. O., Ojalvo, A. G., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560375 · Cited by 139 · see citing works
“A sort of feedback of serine/threonine phosphorylation of IRS underlies the magnitude of insulin stimulation (34).”
BackgroundInsulin receptor endocytosis in the pathophysiology of insulin resistance
Hall, C., Yu, H., & Choi, E. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0456-3 · Cited by 137 · see citing works
Hong, C.-T., Chen, K.-Y., Wang, W., Chiu, J.-Y., Wu, D., Chao, T.-Y., Hu, C.-J., Chau, K.-Y., & Bamodu, O. (2020) · Cells · doi:10.3390/cells9030740 · Cited by 133 · see citing works
“Mechanistically, since increased p85α expression and IRS1 serine phosphorylation are essential for the induction of clinically-apparent IR [32], we demonstrated significant increase in the p-IRS1/IRS1 ratio (123%, p < 0.”
BackgroundMullins, R. J., Mustapić, M., Goetzl, E. J., & Kapogiannis, D. (2017) · Human Brain Mapping · doi:10.1002/hbm.23494 · Cited by 128 · see citing works
“Specific changes in the phosphorylation pattern of IRS-1 resulting in impaired insulin signaling have long been established as pathological markers of IR in peripheral tissues [Copps and White, 2012; Hoehn et al., 2008; Taniguchi et al., 2006].”
Nigi, L., Grieco, G. E., Ventriglia, G., Brusco, N., Mancarella, F., Formichi, C., Dotta, F., & Sebastiani, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123705 · Cited by 126 · see citing works
“Indeed pro-inflammatory cytokines can activate downstream kinases of insulin signaling pathway, including IκB kinase-β (IKKβ), JUN amino-terminal kinase 1 (JNK1) and p38 MAPK, which can contribute to increased serine phosphorylation that inactivates IRS protein and stimulate the production of suppressors of cytokine s…”
BackgroundThe Immune Landscape of Visceral Adipose Tissue During Obesity and Aging
Khan, S. M., Chan, Y. T., Revelo, X. S., & Winer, D. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00267 · Cited by 126 · see citing works
“In turn, proinflammatory cytokine release mediated by immune cells induces serine phosphorylation of insulin receptor substrate-1 (IRS-1) leading to local and systemic insulin resistance, which is thought to contribute toward whole body glucose and fatty acid metabolic dysregulation (24, 25) Furthermore, the obese adi…”
BackgroundWang, H., Li, Q.-M., Yu, N., Chen, W., Zha, X., Wu, D., Pan, L., Duan, J., & Luo, J. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.01.101 · Cited by 124 · see citing works
Benomar, Y., & Taouis, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00140 · Cited by 131 · see citing works
“JNK promotes the serine phosphorylation of IRS-1 that inhibits insulin-dependent IRS-1 tyrosine phosphorylation and downstream signaling (85, 86).”
BackgroundBabu, S., Krishnan, M., Rajagopal, P., Vijayalakshmi, P., Veeraraghavan, V., Govindan, R., & Jayaraman, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173004 · Cited by 124 · see citing works
Inflammation‐mediated metabolic regulation in adipose tissue
Xu, S., Lu, F., Gao, J., & Yuan, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13724 · Cited by 129 · see citing works
“114,169 Mechanically, the TLR4-mediated activation of the IKK β and JNK pathways, likely via MYD88, is thought to directly mediate FA-induced insulin resistance 170 by inducing the serine/ threonine phosphorylation of IRSs and reducing their responsiveness to insulin.”
BackgroundInsulin Signaling in Type 2 Diabetes
Brännmark, C., Nyman, E., Fagerholm, S., Bergenholm, L., Ekstrand, E.-M., Cedersund, G., & Strålfors, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432062 · Cited by 122 · see citing works
“The literature is replete with data implicating the phosphorylation of IRS1 at different serine/threonine residues in positive or negative control of insulin signaling and in positive or negative feedback loops of insulin signaling (16).”
BackgroundMarzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 121 · see citing works
The Role of Catechins in Regulating Diabetes: An Update Review
Wen, L., Wu, D., Tan, X., Zhong, M., Xing, J., Li, W., Li, D., & Cao, F. (2022) · Nutrients · doi:10.3390/nu14214681 · Cited by 130 · see citing works
“, PKC, AKT, mammalian target of rapamycin (mTOR), and extracellular regulated protein kinase (ERK)1/2) [38,39].”
BackgroundmTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes
Minard, A. Y., Tan, S., Yang, P., Fazakerley, D. J., Domanova, W., Parker, B. L., Humphrey, S. J., Jothi, R., Stöckli, J., & James, D. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.086 · Cited by 118 · see citing works
“(n = 3, mean ± SEM, one-sample t test, *p < 0.01). negative feedback loop that triggers insulin resistance and increased adiposity (Copps and White, 2012; Hsu et al., 2011; Um et al., 2004; Yu et al., 2011).”
BackgroundInfluentialInsulin resistance in Alzheimer's disease
Diehl, T. C., Mullins, R. J., & Kapogiannis, D. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.005 · Cited by 119 · see citing works
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 112 · see citing works
Kolnes, K. J., Petersen, M. H., Lien-Iversen, T., Højlund, K., & Jensen, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.737709 · Cited by 112 · see citing works
“Insulin resistance in adipocytes is associated with impaired phosphorylation of insulin receptor substrate 1 (IRS-1) in obesity, which is further impaired in T2DM (Copps and White, 2012).”
BackgroundInfluentialWong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13359 · Cited by 112 · see citing works
“With respect to insulin-dependent signalling pathway, IRS-1 phosphorylation is altered in patients with diabetes.([16]) AMPK (cellular energy sensor) and its upstream kinase (LKB1) can be activated under ATP-depleted metabolic states, and these pathways are essential in promotion of glucose uptake and fat oxidation.”
BackgroundMechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis
Novák, J., Olejníčková, V., Tkáčová, N., & Santulli, G. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22380-3_5 · Cited by 109 · see citing works
“Another putative target, insulin receptor substrate-2 (IRS2) , was confi rmed as miR-33 target by Fernandez-Hernando’s group [ 19 ]—IRS-2, together with IRS-1, are both important for transduction of insulin signaling over the cell membrane and their blockade thus interferes with insulin effects on the cells [ 71 ].”
BackgroundBatista, T. M., Jayavelu, A. K., Albrechtsen, N. J. W., Iovino, S., Lebastchi, J., Pan, H., Dreyfuss, J. M., Krook, A., Zierath, J. R., Mann, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.007 · Cited by 109 · see citing works
“Dysregulated serine phosphorylation of IRS-1 and IRS-2 represents a key mechanism to promote insulin resistance by interference of IRS-1/2 tyrosine phosphorylation and/or increased proteolytic degradation (Copps and White, 2012).”
BackgroundBlázquez, E., Hurtado-Carneiro, V., Ayuso, Y. L. B., Velázquez, E., García‐García, L., Gómez-Oliver, F., Ruiz‐Albusac, J. M., Ávila, J., & Pozo, M. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873301 · Cited by 107 · see citing works
The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes
Hooper, P. L., Balogh, G. E., Rivas, E., Kavanagh, K., & Vı́gh, L. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0493-8 · Cited by 109 · see citing works
“At baseline, obese subjects had increased phosphorylation and thus activation of JNK and pIKK-β with increased inhibitory serine phosphorylation of IRS-1 and reduced GLUT4 response to insulin.”
BackgroundInfluentialHançer, N. J., Qiu, W., Cherella, C. E., Li, Y., Copps, K. D., & White, M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554162 · Cited by 107 · see citing works
“Because a limited number of phospho-specific antibodies were generated in early studies, the phosphorylation of a few Ser/Thr residues (Ser302, Ser-307, Ser-318, Ser-612, and Ser-632) has been interrogated in many different contexts, whereas many others have never been examined (6).”
BackgroundInfluentialSelf-citationInsulin receptor substrate signaling controls cardiac energy metabolism and heart failure
Guo, C., & Guo, S. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0679 · Cited by 107 · see citing works
“Both metabolic and mechanic stresses activate intracellular protein kinases that trigger serine or threonine phosphorylation of IRS proteins, which couple with IRS ubiquitination and degradation (Copps & White 2012).”
BackgroundTeng, W., Zhao, L., Yang, S., Zhang, C., Liu, M., Luo, J., Jin, J., Zhang, M., Bao, C., Li, D., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.023 · Cited by 107 · see citing works
Maternal Early Pregnancy Serum Metabolites and Risk of Gestational Diabetes Mellitus
Enquobahrie, D. A., Denis, M., Tadesse, M. G., Gelaye, B., Ressom, H. W., & Williams, M. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2862 · Cited by 106 · see citing works
IRS proteins and diabetic complications
Lavin, D. P., White, M. F., & Brazil, D. P. (2016) · Diabetologia · doi:10.1007/s00125-016-4072-7 · Cited by 105 · see citing works
“Retinal Müller cells: a primary site of IRS signalling in the retina IRS proteins are heavily phosphorylated on tyrosine, serine and threonine residues [37, 47, 48].”
BackgroundSelf-citationAn, S., Zhao, L., She, Z., Wang, S., Zhang, K., Yu, Q., Zheng, J., Zhang, X., Zhu, X., Bao, R., et al. (2017) · Hepatology · doi:10.1002/hep.29375 · Cited by 104 · see citing works
“(2) The insulin signal-transduction efficacy relies strongly on the phosphorylation of IRS1 at different sites (Ser/Tyr), which is correlated with the subcellular relocalization and proteasome-mediated degradation of IRS1.”
BackgroundTissue‐specific insulin signaling in the regulation of metabolism and aging
Zhang, J., & Liu, F. (2014) · IUBMB Life · doi:10.1002/iub.1293 · Cited by 100 · see citing works
“Insulin signaling is negatively regulated by a number of mechanisms, such as the binding of the adaptor protein Grb10 to the kinase domain of IR ((8), (9)), serine phosphorylation of IRS1 ((10), (11)), and dephosphorylation of IR and IRS1/2 by protein tyrosine phosphatase-1B (PTP-1B) (12).”
BackgroundRebollo‐Hernanz, M., Zhang, Q., Aguilera, Y., Martin-Cabrejas, M. A., & de Mejı́a, E. G. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110672 · Cited by 103 · see citing works
Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity
Yaribeygi, H., Sathyapalan, T., & Sahebkar, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116776 · Cited by 103 · see citing works
“IRS-1 can be also activated by other kinases including ERK1/25, atypical PKC6, S6K17, SIK28, AKT, mTOR9 and ROCK110 as well as other types of kinases such as AMPK11 and GSK312 [33, 34].”
BackgroundCarnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.004 · Cited by 102 · see citing works
Cellular and Molecular Mechanisms of Insulin Resistance
Chandrasekaran, P., & Weiskirchen, R. (2024) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-024-00056-3 · Cited by 126 · see citing works
Dierssen, M., Fructuoso, M., de Lagrán, M. M., Marzia Perluigi, A., & Barone, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00670 · Cited by 101 · see citing works
Barone, E., Di Domenico, F., Cassano, T., Arena, A., Tramutola, A., Lavecchia, M. A., Coccia, R., Butterfield, D. A., & Perluigi, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.012 · Cited by 100 · see citing works
“Indeed, once persistently stimulated, mTOR is able to phosphorylate IRS1 on Ser residues critical for BIR, including Ser307 [19,42] and previous studies from both our groups [43,44] and others [45–48] reported about the hyper-activation of mTOR in AD.”
Background
- Authors
- Copps, K. D., & White, M. F.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- White, M. F.
- ORCID
- White, M. F.
- Venue
- Diabetologia
- Published
- 2012-08-08
- Volume
- 55
- Issue
- 10
- Pages
- 2565-2582
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC4011499
- OpenAlex
- W1982479748
- Cited by
- 1,017
- References
- 185
- Citations by year
- 2026: 72 · 2025: 56 · 2024: 76 · 2023: 83 · 2022: 103 · 2021: 113 · 2020: 83 · 2019: 76 · 2018: 75 · 2017: 70 · 2016: 59 · 2015: 63 · 2014: 51 · 2013: 31 · 2012: 5
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01dk098655-08)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01- DK098655, R01DK038712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin receptor substrate, IRS-1, insulin receptor substrate 2, serine/threonine phosphorylation, insulin sensitivity, insulin resistance, diabetes mellitus, insulin signaling, AMPK, glycogen synthase kinase-3, protein kinase C, Akt, mTOR, hyperinsulinemia, metabolic disorders
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Insulin Resistance, Mice, Transgenic, Phosphorylation, Serine, Threonine, Signal Transduction, Mice, Knockout, Models, Animal, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review